Browse
Site's Items (Sorted by Submit Date in Descending order): 21 to 40 of 135
Publication Year | Title | Author(s) |
---|---|---|
2024 | Editorial: Is it time to include oral vancomycin in therapeutic guidelines for primary sclerosing cholangitis‐associated inflammatory bowel disease? | Ayesha Shah; Gerald Holtmann |
2024 | A Minority of Childhood Disorders of Gut-Brain Interaction Persist Into Adulthood: A Risk-Factor Analysis | Michael P. Jones; Natasha A. Koloski; Marjorie M. Walker; Gerald J. Holtmann ; Ayesha Shah; Guy D. Eslick; Nicholas J. Talley |
2024 | An ‘Adaptive Treatment Strategy’ for Oral Vancomycin in Patients with the Orphan Disease Primary Sclerosing Cholangitis | Ayesha Shah; James Tabibian; Cynthia Buness; Gerald J. Holtmann |
Sep-2024 | A multifaceted ecological approach to explore links between environmental factors and the epidemiology of disorders of gut-brain interaction | Fairlie, Thomas; Shah, Ayesha; Wong, Reuben K; Fang, Xiucai; Ghoshal, Uday C; Kashyap, Purna C; Mulak, Agata; Lee, Yeong Yeh; Sperber, Ami D; Koloski, Natasha ; Moy, Naomi ; Talley, Nicholas J; Jones, Michael P; Holtmann, Gerald |
Feb-2024 | Cost-effectiveness of taurolidine-citrate in a cohort of patients with intestinal failure receiving home parenteral nutrition | Williams, Thomas J; Moy, Naomi ; Kaazan, Patricia; Callaghan, Gavin; Holtmann, Gerald ; Martin, Neal |
Sep-2021 | Dyspepsia: Treatment Options Directed to Specific Targets | Holtmann, Gerald ; Shah, Ayesha; Jacob, Ronen Ben; Koloski, Natasha |
Sep-2022 | Eosinophilic Gastritis and Eosinophilic Duodenitis | Olsson, Sarah; Talley, Nicholas J.; Holtmann, Gerald |
19-Aug-2022 | Efficacy and safety of STW 5-II in patients with functional dyspepsia according RomeIV criteria: Results from a post-hoc analysis of a double-blind, randomized, placebo-controlled, 8-week multicenter trial | Vinson, B; Wargenau, M; Holtmann, G |
Nov-2021 | Epigastric symptom response to low FODMAP dietary advice compared with standard dietetic advice in individuals with functional dyspepsia | Staudacher, Heidi M; Nevin, Amy N; Duff, Christopher; Kendall, Bradley J; Holtmann, Gerald |
Jun-2019 | An in vitro and clinical dose-finding study of antifoaming effects of simethicone during colonoscopy | Kutyla, Marguerite J; Shah, Ayesha; Elson, Jerome; Meeusen, Vera ; O'Connor, Sam; Hourigan, Luke F; Holtmann, Gerald |
2018 | Anti-TNFα therapy in IBD alters brain activity reflecting visceral sensory function and cognitive-affective biases | Gray, Marcus A; Chao, Che-Yung; Staudacher, Heidi M; Kolosky, Natasha A; Talley, Nicholas J; Holtmann, Gerald |
Oct-2022 | Asian-Pacific consensus on small intestinal bacterial overgrowth in gastrointestinal disorders: An initiative of the Indian Neurogastroenterology and Motility Association | Ghoshal, Uday C; Sachdeva, Sanjeev; Ghoshal, Ujjala; Misra, Asha; Puri, Amarender Singh; Pratap, Nitesh; Shah, Ayesha; Rahman, M Masudur; Gwee, Kok Ann; Tan, Victoria P Y; Ahmed, Tahmeed; Lee, Yeong Yeh; Ramakrishna, B S; Talukdar, Rupjyoti; Rana, S V; Sinha, Saroj K; Chen, Minhu; Kim, Nayoung; Holtmann, Gerald |
Feb-2023 | Asia-Pacific guidelines for managing functional dyspepsia overlapping with other gastrointestinal symptoms | Gwee, Kok-Ann; Lee, Yeong Yeh; Suzuki, Hidekazu; Ghoshal, Uday Chand; Holtmann, Gerald ; Bai, Tao; Barbara, Giovanni; Chen, Min-Hu; Chua, Andrew Seng Boon; Gibson, Peter R; Hou, Xiaohua; Liu, Jinsong; Nakajima, Atsushi; Pratap, Nitesh; Sachdeva, Sanjeev; Siah, Kewin Tien Ho; Soh, Alex Yu Sen; Sugano, Kentaro; Tack, Jan; Tan, Victoria Ping Yi; Tang, Xudong; Walker, Marjorie; Wu, Deng-Chyang; Xiao, Ying-Lian; Zulkifli, Khairil Khuzaini; Toh, Clarissa |
Jul-2022 | The role of mood state and emotion regulation in the discrepancy between gastrointestinal symptom burden recorded prospectively and via recall questionnaire | Jones, Michael P; Yun, Grace; Wass, Fiona; Rixon, Hayley; Shah, Ayesha; Walker, Marjorie M; Koloski, Natasha A; Holtmann, Gerald ; Talley, Nicholas J; Beath, Alissa P |
Nov-2014 | Letter: inverse correlation between Helicobacter pylori and obesity - a conclusion too early? Authors' reply | Holtmann, Gerald ; Talley, N. J. ; Morrison, M. |
Nov-2017 | A randomized placebo-controlled trial on the effects of Menthacarin, a proprietary peppermint- and caraway-oil-preparation, on symptoms and quality of life in patients with functional dyspepsia | Rich, G; Shah, A. ; Koloski, N. ; Funk, P; Stracke, B; Köhler, S; Holtmann, Gerald |
Aug-2019 | Dysbiosis of the Duodenal Mucosal Microbiota Is Associated With Increased Small Intestinal Permeability in Chronic Liver Disease | Raj, Ashok S; Shanahan, Erin R; Tran, Cuong D; Bhat, Purnima; Fletcher, Linda M; Vesey, David A; Morrison, Mark; Holtmann, Gerald ; Macdonald, Graeme A |
2021 | Improving the Quality of Bowel Preparation: Rewarding Patients for Success or Intensive Patient Education? | Kutyla, Marguerite J; Gray, Marcus A; von Hippel, Courtney; Hourigan, Luke F; Kendall, Bradley J; Whaley, Amanda J; O'Connor, Sam; Holtmann, Gerald |
10-May-2023 | Validation of the Structured Assessment of Gastrointestinal Symptoms Scale to Support Standardized Evaluation and Follow-up | Hammer, Johann; Holtmann, Gerald ; Hammer, Karin |
1-Dec-2021 | Clusters of community-dwelling individuals empirically derived from stool diaries correspond with clinically meaningful outcomes | Jones, Michael P; Walter, Susanna; Talley, Nicholas J; Walker, Marjorie M; Holtmann, Gerald ; Shah, Ayesha; D'Amato, Mauro; Agréus, Lars; Andreasson, Anna |
Site's Items (Sorted by Submit Date in Descending order): 21 to 40 of 135
By people
- 117 Holtmann, Gerald
- 62 Shah, Ayesha
- 47 Talley, Nicholas J
- 26 Koloski, Natasha
- 25 Jones, Michael P
- 25 Morrison, Mark
- 24 Walker, Marjorie M
- 14 Koloski, Natasha A
- 12 Keely, Simon
- 10 Fairlie, Thomas
- 10 Ghoshal, Uday C
- next >